333 related articles for article (PubMed ID: 27051585)
1. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links.
Jurjus A; Eid A; Al Kattar S; Zeenny MN; Gerges-Geagea A; Haydar H; Hilal A; Oueidat D; Matar M; Tawilah J; Hussein IH; Schembri-Wismayer P; Cappello F; Tomasello G; Leone A; Jurjus RA
BBA Clin; 2016 Jun; 5():16-24. PubMed ID: 27051585
[TBL] [Abstract][Full Text] [Related]
2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
[TBL] [Abstract][Full Text] [Related]
4. Role of Inflammation in the Development of Colorectal Cancer.
Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
[TBL] [Abstract][Full Text] [Related]
5. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice.
Kattar SA; Jurjus R; Pinon A; Leger DY; Jurjus A; Boukarim C; Diab-Assaf M; Liagre B
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664279
[TBL] [Abstract][Full Text] [Related]
6. Highlights on two decades with microbiota and inflammatory bowel disease from etiology to therapy.
Hajj Hussein I; Dosh L; Al Qassab M; Jurjus R; El Masri J; Abi Nader C; Rappa F; Leone A; Jurjus A
Transpl Immunol; 2023 Jun; 78():101835. PubMed ID: 37030558
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer.
Velikova TV; Miteva L; Stanilov N; Spassova Z; Stanilova SA
World J Gastroenterol; 2020 Apr; 26(16):1912-1925. PubMed ID: 32390702
[TBL] [Abstract][Full Text] [Related]
8. Effects of Probiotics at the Interface of Metabolism and Immunity to Prevent Colorectal Cancer-Associated Gut Inflammation: A Systematic Network and Meta-Analysis With Molecular Docking Studies.
Patra S; Sahu N; Saxena S; Pradhan B; Nayak SK; Roychowdhury A
Front Microbiol; 2022; 13():878297. PubMed ID: 35711771
[TBL] [Abstract][Full Text] [Related]
9. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease.
Shen Q; Huang Z; Yao J; Jin Y
J Adv Res; 2022 Mar; 37():221-233. PubMed ID: 35499059
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives.
Majumder S; Shivaji UN; Kasturi R; Sigamani A; Ghosh S; Iacucci M
World J Gastrointest Oncol; 2022 Mar; 14(3):547-567. PubMed ID: 35321275
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress, Inflammation and Colorectal Cancer: An Overview.
Bardelčíková A; Šoltys J; Mojžiš J
Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107276
[TBL] [Abstract][Full Text] [Related]
14. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
Salla M; Guo J; Joshi H; Gordon M; Dooky H; Lai J; Capicio S; Armstrong H; Valcheva R; Dyck JRB; Thiesen A; Wine E; Dieleman LA; Baksh S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983040
[TBL] [Abstract][Full Text] [Related]
15. Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review).
Wang Z; Chang Y; Sun H; Li Y; Tang T
Oncol Lett; 2024 Jun; 27(6):257. PubMed ID: 38646499
[TBL] [Abstract][Full Text] [Related]
16. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
19. Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
Ma Y; Zhang Y; Xiang J; Xiang S; Zhao Y; Xiao M; Du F; Ji H; Kaboli PJ; Wu X; Li M; Wen Q; Shen J; Yang Z; Li J; Xiao Z
Front Cell Infect Microbiol; 2021; 11():599734. PubMed ID: 33738265
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 Plays Multiple Oncometabolic Roles in Colitis-Associated Carcinoma and Colorectal Cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α Signaling Pathways in Zebrafish.
Lai CY; Yeh KY; Liu BF; Chang TM; Chang CH; Liao YF; Liu YW; Her GM
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
